Drug-induced liver injuries
The aim of review. To demonstrate modern concept on management and prevention in patients with drug-induced liver injury (DILI).Key points. DILI have a wide spectrum of clinical symptoms, from asymptomatic elevation of serum transaminase activity to fulminant liver failure. The task of clinician – t...
Saved in:
Main Author: | S. F. Galimova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2014-07-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1087 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-Induced Liver Injuries (Clinical Guidelines for Physicians)
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01) -
Drug-induced liver injuries (Part 1)
by: S. F. Galimova
Published: (2012-06-01) -
The feasibility of using liver function indices and FibroScan in combination to predict the occurrence of anti-tuberculosis drug-induced liver injury in Patients with liver disease
by: Shaoqiang Wu, et al.
Published: (2025-01-01) -
Untangling a case of dapsone-induced acute liver injury
by: V Meghana, et al.
Published: (2025-01-01) -
Slow Metabolism–Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone‐Induced Obesity‐Specific Liver Injury
by: Guanting Li, et al.
Published: (2025-01-01)